Tracer Biotechnologies, a next-generation diagnostics company, today announced a multi-year project with AstraZeneca (LSE/STO/Nasdaq: AZN). The agreem ...

IlluminaThe comprehensive method provides improved detection and greater insight on the complex disease that impacts millions of people worldwideOriginally published on Illumina News CenterThe ...

The Vericheck ddPCR Empty-Full Capsid Kits comprise a capsid detection assay in FAM and an ITR-2 assay in HEX. The ITR-2 ...

Neoadjuvant chemotherapy is the standard-of-care treatment for patients with early-stage TNBC ... Improved pathologic ...

SHR-A1811 showed promising antitumor activity and acceptable tolerability in patients with HER2-positive breast cancer, ...

According to a new comprehensive report from The Insight Partners, Global Genotyping Market value is expected to reach US$ 154.35 billion by 2031 from US$ 30.44 billion in 2023 at a CAGR of 22.5%.

Hospital and ICU admission rates within 30 days after COVID-19 infection were greater in patients with inborn errors of immunity (IEI).

Nonetheless, the findings underscore the need to integrate PCR into standard diagnostic protocols. By reducing reliance on ...

"This study underscores the impact of dd-cfDNA as a critical biomarker for early AMR detection, providing healthcare teams with timely data enabling them to initiate treatments sooner," said Dr. Aylin ...

Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

The research, published in the renowned journal ScienceDirect, utilised standard ATR-FTIR and PCR-based methods to detect GM maize. Samples were collected from near Swami Muthayan Stadium ...